OTHARIS

Immunovant, Inc.

IMVT · Nasdaq · US

USD 28.58 -2.01% today

As of Nov 02, 2026 20:47 UTC — not a live feed

52-week range
USD 21.43 lowat 30% of its rangehigh 45.42
Market Cap
5.9B USD
Sector
Healthcare
Industry
Biotechnology

Immunovant, Inc. (IMVT) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. At USD 28.58 it trades at 30% of its 52-week range (USD 21.43 – 45.42).

Otharis Plus · ProAnalysed Nov 02, 2026 from its filings

Is Immunovant worth more than its price — and is its growth accelerating?

Two complete methods, run on IMVT's own numbers: Benjamin Graham's value test and the Otharis Growth Score. Every number is real and computed — never estimated.

Value Investing · Benjamin Graham7 criteria · value vs price · margin of safety
  • Size
  • Financial strength
  • Earnings stability
  • Dividend record
  • Earnings growth
  • Moderate P/E
  • Moderate price-to-book
Growth Investing · Otharis Growth Score7 criteria · speed · acceleration · margins
  • Revenue growth
  • Acceleration
  • EPS growth
  • Latest quarter
  • Margin expansion
  • Growth efficiency
  • Price momentum

The verdict, the values and every number behind them are inside Otharis.

✨

Otharis Research Free

A real, deterministic 22-section research report for IMVT - every line tagged FACT, MODEL OUTPUT, ASSUMPTION, ESTIMATE or RULE-BASED INTERPRETATION. 2 reports a day with a free account.

Unlock IMVT’s full analysis →

Start with a free account · Value & Growth analysis included in Otharis Plus and Pro